These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11710544)

  • 1. Differential activities of decapeptide agonists of human C5a: the conformational effects of backbone N-methylation.
    Vogen SM; Paczkowski NJ; Kirnarsky L; Short A; Whitmore JB; Sherman SA; Taylor SM; Sanderson SD
    Int Immunopharmacol; 2001 Nov; 1(12):2151-62. PubMed ID: 11710544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity.
    Finch AM; Vogen SM; Sherman SA; Kirnarsky L; Taylor SM; Sanderson SD
    J Med Chem; 1997 Mar; 40(6):877-84. PubMed ID: 9083476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of Lys68 in decepeptide agonists of C5a on C5a receptor binding, activation and selectivity.
    Vogen SM; Finch AM; Wadi SK; Thatcher J; Monk PN; Taylor SM; Sanderson SD
    J Pept Res; 1999 Jan; 53(1):8-17. PubMed ID: 10195437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response-selective C5a agonists: differential effects on neutropenia and hypotension in the rat.
    Short AJ; Paczkowski NJ; Vogen SM; Sanderson SD; Taylor SM
    Br J Pharmacol; 1999 Oct; 128(3):511-4. PubMed ID: 10516626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contractile effect of anaphylatoxin C5a and of a mimetic peptide on the human umbilical artery: further evidence for leukocyte-dependent vasomotion.
    Fortin JP; Bouthillier J; St-Pierre SA; Marceau F
    J Cardiovasc Pharmacol; 2002 Dec; 40(6):815-21. PubMed ID: 12451314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decapeptide agonists of human C5a: the relationship between conformation and spasmogenic and platelet aggregatory activities.
    Sanderson SD; Kirnarsky L; Sherman SA; Ember JA; Finch AM; Taylor SM
    J Med Chem; 1994 Sep; 37(19):3171-80. PubMed ID: 7932541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of an isolated helical capping box in solution by hydrophobic interactions: evidence from the NMR study of bioactive peptides from the C-terminus of human C5a anaphylatoxin.
    Ni F; Carpenter KA; Ripoll DR; Sanderson SD; Hugli TE
    Biopolymers; 1996 Jan; 38(1):31-41. PubMed ID: 8679942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decapeptide agonists of human C5a: the relationship between conformation and neutrophil response.
    Sanderson SD; Kirnarsky L; Sherman SA; Vogen SM; Prakash O; Ember JA; Finch AM; Taylor SM
    J Med Chem; 1995 Sep; 38(18):3669-75. PubMed ID: 7658455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of response-selective agonists of human C5a anaphylatoxin: conformational, biological, and therapeutic considerations.
    Taylor SM; Sherman SA; Kirnarsky L; Sanderson SD
    Curr Med Chem; 2001 May; 8(6):675-84. PubMed ID: 11281848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of structural elements related to the biological activities of a potent decapeptide agonist of human C5a anaphylatoxin.
    Vogen SM; Prakash O; Kirnarsky L; Sanderson SD; Sherman SA
    J Pept Res; 1999 Jul; 54(1):74-84. PubMed ID: 10448972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species dependence for binding of small molecule agonist and antagonists to the C5a receptor on polymorphonuclear leukocytes.
    Woodruff TM; Strachan AJ; Sanderson SD; Monk PN; Wong AK; Fairlie DP; Taylor SM
    Inflammation; 2001 Jun; 25(3):171-7. PubMed ID: 11403208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic C5a receptor agonists. Pharmacology, metabolism and in vivo cardiovascular and hematologic effects.
    Drapeau G; Brochu S; Godin D; Levesque L; Rioux F; Marceau F
    Biochem Pharmacol; 1993 Mar; 45(6):1289-99. PubMed ID: 8466549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and preliminary pharmacological characterization of the anaphylatoxin C5a receptor in the rabbit.
    Bachvarov DR; Houle S; Bachvarova M; Bouthillier J; St-Pierre SA; Fukuoka Y; Ember JA; Marceau F
    Br J Pharmacol; 1999 Sep; 128(2):321-6. PubMed ID: 10510441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists.
    Li XX; Clark RJ; Woodruff TM
    Int Immunopharmacol; 2021 Nov; 100():108074. PubMed ID: 34454293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR analysis of a potent decapeptide agonist of human C5a anaphylatoxin.
    Vogen SM; Prakash O; Kirnarsky L; Sanderson SD; Sherman SA
    J Pept Res; 1998 Mar; 51(3):226-34. PubMed ID: 9531426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonistic peptides against human anaphylatoxin C5a.
    Kaneko Y; Okada N; Baranyi L; Azuma T; Okada H
    Immunology; 1995 Sep; 86(1):149-54. PubMed ID: 7590876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function relationships of human C5a and C5aR.
    Huber-Lang MS; Sarma JV; McGuire SR; Lu KT; Padgaonkar VA; Younkin EM; Guo RF; Weber CH; Zuiderweg ER; Zetoune FS; Ward PA
    J Immunol; 2003 Jun; 170(12):6115-24. PubMed ID: 12794141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
    Wong AK; Finch AM; Pierens GK; Craik DJ; Taylor SM; Fairlie DP
    J Med Chem; 1998 Aug; 41(18):3417-25. PubMed ID: 9719594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of antagonists of the C5a receptor.
    Paczkowski NJ; Finch AM; Whitmore JB; Short AJ; Wong AK; Monk PN; Cain SA; Fairlie DP; Taylor SM
    Br J Pharmacol; 1999 Dec; 128(7):1461-6. PubMed ID: 10602324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel C5a receptor antagonists regulate neutrophil functions in vitro and in vivo.
    Pellas TC; Boyar W; van Oostrum J; Wasvary J; Fryer LR; Pastor G; Sills M; Braunwalder A; Yarwood DR; Kramer R; Kimble E; Hadala J; Haston W; Moreira-Ludewig R; Uziel-Fusi S; Peters P; Bill K; Wennogle LP
    J Immunol; 1998 Jun; 160(11):5616-21. PubMed ID: 9605167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.